Latest Articles

Publication Date
All News Scientific
Absci Corp’s 2025 Q4 Call: FDA Delays, Oncology Partnership Shifts, and ABS-201 Timeline Contradictions - Bitget

Absci Corp’s 2025 Q4 Call: FDA Delays, Oncology Partnership Shifts, and ABS-201 Timeline Contradictions Bitget

Published: March 25, 2026, 12:10 a.m.
Read Full Article
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
Read Full Article
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
Read Full Article
Experts discuss advances in gynaecological oncology at meet in Puducherry - The Hindu

Experts discuss advances in gynaecological oncology at meet in Puducherry The Hindu

Published: Feb. 24, 2026, 3:22 p.m.
Read Full Article
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress - The Manila Times

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress The Manila Times

Published: Feb. 23, 2026, 1:16 p.m.
Read Full Article
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress - Yahoo Finance

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress Yahoo Finance

Published: Feb. 23, 2026, 1 p.m.
Read Full Article
From bench to bedside: unlocking the anti-inflammatory, antioxidant, and anticancer promise of curcumin in gynecology.

Curcumin, a bioactive polyphenol derived from turmeric (Curcuma longa), has garnered substantial attention for its potent anti-inflammatory, antioxidant, and antineoplastic properties. This review explores the therapeutic potential of curcumin in …

Published: Feb. 20, 2026, midnight
Read Full Article
curcumin endometriosis gynecological cancer menopause polycystic ovary syndrome polyphenols premenstrual syndrome
Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Feb. 19, 2026, 3:47 p.m.
Read Full Article
Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer - Targeted Oncology

Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer Targeted Oncology

Published: Feb. 6, 2026, 10:05 p.m.
Read Full Article
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News

How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News

Published: Feb. 5, 2026, 5:03 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!